Wide-Moat Stocks: Companies Dominating Their Markets
Warren Buffett popularized the concept of an economic moat — a durable competitive advantage that protects a company’s profits and market share from rivals over time, much like the water surrounding a medieval castle protected its inhabitants. Morningstar later formalized the idea into a three-tier rating system: wide moat (advantages expected to last 20+ years), narrow moat (at least 10 years), and no moat.
Morningstar identifies five sources from which a moat can be derived:
- Network effect: The product becomes more valuable as more people use it — Visa, Mastercard, and Meta are classic examples.
- Intangible assets: Patents, brands, and regulatory licenses that block competitors — Coca-Cola’s brand power and Moody’s regulatory standing fall here.
- Switching costs: Customers face high costs or friction when changing providers — Microsoft’s enterprise software suite is a textbook case.
- Cost advantage: Structural cost efficiencies that competitors cannot replicate — Waste Management’s vertically integrated network of landfills, recycling centers, and exclusive municipal licenses is nearly impossible for new entrants to match.
- Efficient scale: Markets that naturally support only one or a few players — Union Pacific in railroads and ASML in extreme ultraviolet lithography, where it holds a near-monopoly on EUV systems essential for producing the most advanced semiconductor chips.
Wide-moat companies cluster heavily in technology, healthcare, consumer staples, financials, and industrials. Six of the Magnificent Seven — Nvidia, Meta Platforms, Apple, Amazon, Microsoft, and Alphabet — carry wide-moat designations. Beyond tech, names like LVMH, Novo Nordisk, and Ferrari maintain advantages rooted in heritage, patents, and exclusivity that competitors simply cannot replicate.
For those interested in a fund-based approach, the VanEck Morningstar Wide Moat ETF (MOAT) tracks the Morningstar Wide Moat Focus Index, which selects attractively priced companies with wide-moat ratings and rebalances quarterly across two staggered sub-portfolios of 40 stocks each.
Regulated brokerThe table below lists companies with unrivalled economic moats — businesses with dominant, hard-to-replicate market positions. All data including price and market cap are updated regularly.
| Stock | Price | Change % | Marketcap |
|---|---|---|---|
Gilead Sciences GILD | $137.21 | 2.76% | 170.34B |
Boeing BA | $195.18 | 2.98% | 153.38B |
| $69.65 | 1.04% | 31.74B | |
Walt Disney DIS | $99.49 | 0.29% | 176.43B |
Corteva CTVA | $77.34 | 0.94% | 52.26B |
| $57.46 | 1.12% | 117.02B | |
| $298.79 | 2.27% | 3.61T | |
Veeva Systems VEEV | $184.14 | 0.78% | 30.27B |
| $64.50 | 0.88% | 108.27B | |
TransUnion TRU | $70.58 | 1.58% | 13.71B |
U.S. Bancorp USB | $51.25 | 0.10% | 79.63B |
| $111.28 | 0.42% | 31.47B | |
| $191.37 | 0.51% | 48.36B | |
Allegion ALLE | $142.51 | 0.92% | 12.28B |
Kenvue KVUE | $17.42 | 0.09% | 33.38B |
| $87.91 | 2.15% | 17.42B | |
Pfizer PFE | $26.99 | 1.53% | 153.53B |
| $264.49 | 0.19% | 7.14B | |
Nike NKE | $52.39 | 1.96% | 77.56B |
| $66.62 | 1.64% | 17.06B | |
| $95.94 | 0.64% | 81.46B | |
Teradyne TER | $290.83 | 3.83% | 45.53B |
| $85.93 | 0.39% | 31.08B | |
| $21.07 | 0.19% | 6.28B | |
Adobe ADBE | $248.15 | 0.88% | 101.87B |
| $62.97 | 0.51% | 34.08B | |
MarketAxess MKTX | $174.01 | 0.37% | 6.47B |
| $408.27 | 2.43% | 16.02B | |
Brown Forman Inc BF-B | $22.80 | 2.19% | 10.46B |
Salesforce CRM | $195.35 | 0.19% | 183.05B |
Charles Schwab SCHW | $94.67 | 0.72% | 168.22B |
Emerson EMR | $128.16 | 1.34% | 72.06B |
Amazon AMZN | $205.37 | 1.63% | 2.20T |
| $1,068.85 | 2.18% | 52.50B | |
Autodesk ADSK | $247.99 | 0.14% | 52.57B |
| $281.01 | 1.11% | 62.57B | |
Amgen AMGN | $347.80 | 0.61% | 187.49B |
Otis Worldwide OTIS | $79.54 | 0.87% | 31.00B |
| $474.66 | 0.95% | 176.33B | |
Lam Research LRCX | $228.36 | 2.41% | 286.83B |
Masco MAS | $58.84 | 1.47% | 11.98B |
Mondelez MDLZ | $56.21 | 0.50% | 72.53B |
Honeywell HON | $221.50 | 3.29% | 140.80B |
| $707.20 | 0.97% | 100.93B | |
Equifax EFX | $178.02 | 1.92% | 21.79B |
IDEX IEX | $184.18 | 1.71% | 13.79B |
Microsoft MSFT | $381.85 | 1.84% | 2.84T |
Danaher DHR | $189.33 | 0.41% | 133.88B |
Merck MRK | $114.17 | 0.03% | 282.27B |
| $149.66 | 1.48% | 26.05B | |
| $237.21 | 1.30% | 17.10B | |
Apple AAPL | $247.55 | 0.57% | 3.64T |
